Can less be more? new study tests safer blood thinner doses for ECMO patients
NCT ID NCT07499037
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving lower doses of two blood thinners (argatroban and enoxaparin) to adults on ECMO (a machine that helps the heart and lungs) is safe and works well. The goal is to reduce bleeding and clotting problems. About 200 people with pneumonia or heart failure will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Motol
Prague, 150 00, Czechia
-
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, 708 52, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- Poles apart? nordic walking may outpace standard rehab for heart failure
- Could a gentler tug on the Heart's reins spark recovery?
- Can slow breathing soothe a failing heart?
- Can shedding pounds reboot the Heart's exercise engine?